SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-342149
Filing Date
2018-12-04
Accepted
2018-12-04 16:03:59
Documents
5
Period of Report
2018-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d666498d8k.htm 8-K 21005
2 EX-10.1 d666498dex101.htm EX-10.1 296600
3 EX-10.2 d666498dex102.htm EX-10.2 77291
4 GRAPHIC g666498g1203174532705.jpg GRAPHIC 15774
5 GRAPHIC g666498g1203181719988.jpg GRAPHIC 24077
  Complete submission text file 0001193125-18-342149.txt   451318
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33095 | Film No.: 181216847
SIC: 2834 Pharmaceutical Preparations